In Brief: NDAC
This article was originally published in The Tan Sheet
Executive Summary
NDAC: Meeting of FDA's Nonprescription Drugs Advisory Committee tentatively scheduled for Jan. 13-14 canceled due to lack of agenda items. The next meeting of the committee is tentatively scheduled to be held March 11-13...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning